Chia Tai Tianqing Pharmaceutical Group Co., Ltd. clinical trials
Acquired by Sino Biopharmaceutical Limited
The registry lists 320 studies whose lead sponsor is Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. 76 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 20, 2026.
Status
Where
- China
- 317
Registry sponsor names on this page
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.320 studies
Something wrong with this grouping? Tell us on the Sino Biopharmaceutical Limited page.
Studies
Recruiting first, then most recently updated. Showing 50 of 320. List all 320 → · All Sino Biopharmaceutical Limited studies →
- Clinical Trial of TQB3126 for Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Breast Cancer SubjectsRecruitingNCT07697443Phase 1/2
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- A Clinical Trial of TQF3250 Capsules in Overweight/Obese Trial Participants With Poor Weight Control Through Simple Lifestyle InterventionRecruitingNCT07798284Phase 1
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- Clinical Trial of TQA3605 Tablet in Combination With Nucleos(t)Ide Analogues(NAs) Versus NAs Alone for the Treatment of Patients With Chronic Hepatitis B Virus Infection Who Have Undergone Treatment and Exhibit Low Viral Load or Poor ResponseNot yet recruitingNCT07797231Phase 3
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- Evaluation of the Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseRecruitingNCT07464587Phase 3
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- Treatment of Chinese Adult Subjects With Moderate to Severe Crohn's Disease With Tabellvi®RecruitingNCT07663526Phase 4
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal CancerRecruitingNCT07367516Phase 1/2
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- A Clinical Trial of Taibowei® Adalimumab Injection in the Treatment of Chinese Pediatric Patients With Moderately to Severely Active Crohn's DiseaseRecruitingNCT07564505Phase 4
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- A Clinical Trial on the Efficacy and Safety of TQB6411 for InjectionRecruitingNCT07367529Phase 1/2
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative BacteriaRecruitingNCT07512596Phase 2
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- A Clinical Trial Evaluating TQF3250 Capsules in Patients With Type 2 Diabetes Mellitus and Overweight/ObesityRecruitingNCT07747857Phase 1
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host DiseaseRecruitingNCT06300320Phase 2
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- A Clinical Trial on the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TQB3019 Capsule in Subjects With Advanced Malignant TumorsRecruitingNCT06943677Phase 1
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- A Clinical Trial to Evaluate the Efficacy and Safety of TQB3909 Tablets Versus Investigator's Choice in the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)Not yet recruitingNCT07753369Phase 3
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- Clinical Trial Evaluating the Efficacy and Safety of TQB3454 Tablets in Participants With Advanced Solid TumorsNot yet recruitingNCT07738679Phase 2
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- A Clinical Study of TQB3107 Tablets in Patients With Malignant TumorsRecruitingNCT06413953Phase 1
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- A Multicenter, Open-label Study on the Efficacy and Safety of Tebiovio® (Adalimumab) in Treating Chinese Children With Severe Plaque PsoriasisRecruitingNCT07663331Phase 4
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of TQ05105 Tablets in Subjects With Intermediate/High-risk MyelofibrosisRecruitingNCT07551427Phase 2
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus ErythematosusRecruitingNCT07509892Phase 2
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- To Evaluate the Tolerability and Pharmacokinetics of TQB3142 for Injection in Patients With Advanced Malignant TumorsRecruitingNCT07338838Phase 1
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform NeurofibromasRecruitingNCT07407803Phase 3
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple MyelomaNot yet recruitingNCT07569757Phase 3
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- Clinical Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules in the Treatment of Advanced or Unresectable Alveolar Soft Part SarcomaRecruitingNCT07548177Phase 2
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- A Clinical Study to Evaluate the Pharmacokinetics and Safety of Anecatibin Fumarate Capsules in Subjects With Impaired Liver Function Versus Normal Liver FunctionNot yet recruitingNCT07538973Phase 1
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- Clinical Trial of TQB3205 Capsule in Subjects With Advanced Malignant TumorsRecruitingNCT07482592Phase 1
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- A Clinical Trail of Adalimumab in Treating Chinese Children With Severe Plaque PsoriasisNot yet recruitingNCT07529925Phase 4
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Hepatic Impairment SubjectsRecruitingNCT07480824Phase 1
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort CRecruitingNCT06821503Phase 1/2
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- Clinical Trial of TQB2825 Injection Combined Immunochemotherapy in Subjects With Diffuse Large B Cell LymphomaRecruitingNCT06829771Phase 1/2
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3122 Capsules in Subjects With Advanced Malignant TumorsRecruitingNCT07269145Phase 1
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- A Clinical Trial Evaluating TQF3250 Capsules in Healthy Adult SubjectsRecruitingNCT07327281Phase 1
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid CarcinomaRecruitingNCT06860971Phase 3
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3217 Tablets in Subjects With Advanced Malignant TumorsNot yet recruitingNCT07291050Phase 1
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)RecruitingNCT06122831Phase 1/2
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host DiseaseRecruitingNCT06682169Phase 3
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- Clinical Trial of TQB3002 in Patients With Advanced CancersRecruitingNCT06662760Phase 1
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- Clinical Trial to Evaluate the Tolerance of TQB3201 TabletsNot yet recruitingNCT07172126Phase 1/2
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseNot yet recruitingNCT07147946Phase 3
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in AdultsNot yet recruitingNCT07083739Phase 2
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- A Clinical Trial of TQB3909 Tablets in Combination With Azacitidine for the Treatment of Myeloid MalignanciesRecruitingNCT07011186Phase 1/2
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune ThrombocytopeniaRecruitingNCT06900920Phase 3
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- Clinical Trial of TQB3702 Tablets in Subjects With Systemic Lupus Erythematosus (SLE)Not yet recruitingNCT06859931Phase 2
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed ShockRecruitingNCT06351150Phase 3
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy.RecruitingNCT05922345Phase 3
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell LymphomaRecruitingNCT06566586Phase 2
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- Drug-Drug Interaction (DDI) Study for TQB3616Not yet recruitingNCT06662773Phase 1
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- A Clinical Trial to Evaluate the Efficacy and Safety of TQA3810 Tablets in Combination/Non Combination With Nucleoside (Acid) Analogues in Patients With Primary/Treated Chronic Hepatitis BRecruitingNCT06566248Phase 2
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- A Clinical Trial of TQB3455 Tablets in Patients With Hematological MalignanciesRecruitingNCT06550713Phase 1
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacokinetic of TQB3702 Tablets in Healthy Adult SubjectsRecruitingNCT06448273Phase 1
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid TumorsNot yet recruitingNCT06500091Phase 2
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group
- A Clinical Study of TQB2450 Combined With Anlotinib in Limited-Stage Small Cell Lung Cancer PatientsNot yet recruitingNCT06469879Phase 3
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — acquired company within the Sino Biopharmaceutical Limited group